32811-76-0 Usage
Description
Methyl 3-Hydroxycyclopentanecarboxylate is an organic chemical compound characterized by its molecular formula C7H12O3. It is a colorless, viscous liquid with a distinctive sweet odor. This versatile chemical is widely recognized for its utility as a building block in the synthesis of a broad range of products, including pharmaceuticals, agrochemicals, and other organic compounds.
Uses
Used in Pharmaceutical Industry:
Methyl 3-Hydroxycyclopentanecarboxylate is utilized as an intermediate in the synthesis of various drugs and active pharmaceutical ingredients. Its role in drug development is pivotal, as it contributes to the creation of new medications that address a spectrum of health conditions.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 3-Hydroxycyclopentanecarboxylate serves as a key intermediate in the production of compounds that are integral to agricultural applications. Its presence in this industry underscores its importance in developing solutions that enhance crop protection and productivity.
Used in Chemical Industry:
Methyl 3-Hydroxycyclopentanecarboxylate's applications extend to the broader chemical industry, where it is employed in the synthesis of a variety of organic compounds. Its versatility and chemical properties make it a valuable component in numerous chemical processes and end products.
Check Digit Verification of cas no
The CAS Registry Mumber 32811-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,8,1 and 1 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 32811-76:
(7*3)+(6*2)+(5*8)+(4*1)+(3*1)+(2*7)+(1*6)=100
100 % 10 = 0
So 32811-76-0 is a valid CAS Registry Number.
32811-76-0Relevant articles and documents
INHIBITORS OF RHO/MRTF/SRF-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME
-
Paragraph 0071; 0235-0236, (2019/10/20)
Disclosed herein are inhibitors of Rho/MRTF/SRF-mediated gene transcription, and methods for their use in treating or preventing diseases such as cancer and fibrosis. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically accept
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS
-
Page/Page column 77; 78, (2017/03/08)
Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
Glutaminase inhibitors as well as compositions and applications thereof
-
Paragraph 0408; 0412; 0413; 0414, (2018/01/09)
The invention provides a series of heterocyclic compounds expressed in a formula I. The compound comprises glutaminase inhibition activity, and can be used for treating diseases and symptoms related to dysfunction of glutaminase or raising activity of glutaminase.
